Picture of Belluscura logo

BELL Belluscura News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Statement re US Subsidiary Chapter 7 Update

RNS Number : 5342F

Belluscura PLC

30 October 2025

 

The following amendment has been made to the "Statement re US Subsidiary Chapter 7 Update" announcement released on 30/10/25 at 10.38 under RNS No 5186F.

 

The announcement was issued today, 30 October 2025, and confirms that on 29 October 2025 Belluscura LLC filed for Chapter 7 Bankruptcy under the U.S Bankruptcy Code.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

 

 

30 October 2025

 

Belluscura plc

("Belluscura" or the "Company")

 

Belluscura LLC

 

Further to the notification of 28 October 2025, the Company confirms that on 29 October 2025 Belluscura LLC filed for Chapter 7 Bankruptcy under the U.S Bankruptcy Code.

 

For further information please contact:

 

Belluscura plcTel: +44 (0)20 3128 8100
Paul Tuson, Chairman
SPARK Advisory Partners Limited
Nominated Adviser
Tel: +44 (0)20 3368 3550
Neil Baldwin
Dowgate Capital Limited
Joint Broker
Tel: +44 (0)20 3903 7715
Russell Cook / Daniel Ingram (Corporate Finance)
Allenby Capital Ltd
Joint Broker
Tel: +44 (0)20 3328 5656
Amrit Nahal (Sales and Corporate Broking)
Jeremy Porter / Lauren Wright (Corporate Finance)
Tel: +44 (0)20 3128 8100
email:Belluscura@mhpgroup.com
    This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     STREAFEEDASSFFA

Recent news on Belluscura

See all news